Characterisation of progenitor cells in human atherosclerotic vessels

Evelyn Torsney1, Kaushik Mandal, Alison Halliday

  • 1Department of Cardiac and Vascular Sciences, St. George's, University of London, Cranmer Terrace, London SW17 0RE, UK. etorsney@sgul.ac.uk

Atherosclerosis
|June 22, 2006
PubMed

Insights

Vascular progenitor cells are present in human atherosclerotic lesions, with increased numbers found in the adventitia of diseased arteries. These cells may contribute to the development of atherosclerosis.

Area of Science:

  • Vascular Biology
  • Atherosclerosis Research
  • Stem Cell Biology

Background:

  • Animal models indicate endothelial and smooth muscle progenitor cells drive atherosclerosis.
  • The presence and role of progenitor cells in human atherosclerotic vessels remain uncharacterized.

Purpose of the Study:

  • To investigate the existence and characteristics of vascular progenitor cells in human atherosclerotic arteries.
  • To quantify progenitor cell presence in normal versus atherosclerotic human vessels.

Main Methods:

  • Human arterial segments (internal mammary artery, aorta) from bypass surgery patients were analyzed.
  • Immunofluorescence staining was employed to detect progenitor cell markers (CD34, Sca-1, c-kit, VEGFR2, CD133).

Main Results:

  • Vascular progenitor cells were identified in neointimal lesions and adventitia of atherosclerotic arteries.
  • A two- to three-fold increase in adventitial progenitor cells was observed in atherosclerotic vessels compared to controls.
  • Increased frequency of VEGFR2-expressing cells was noted in atherosclerotic adventitia (p<0.05).

Conclusions:

  • This study provides the first evidence of vascular progenitor cells within human atherosclerotic lesions.
  • An elevated number of progenitor cells in the adventitia of human atherosclerotic vessels suggests a role in disease progression.
  • These progenitor cells may serve as a source for smooth muscle cells, macrophages, and endothelial cells in atherosclerotic plaques.

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Inflammation01:38

Inflammation

Overview
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Production of Formed Elements01:34

Production of Formed Elements

Hemangioblasts are multipotent stem cells originating from the mesoderm. They give rise to hematopoietic stem cells (HSCs), which undergo hematopoiesis to produce all the formed elements of blood. This process is regulated by a complex network of hematopoietic growth factors, including transcription factors, growth factors, and cytokines. These factors stimulate the HSCs to divide and differentiate, though some HSCs remain undifferentiated to maintain a self-renewing pool.
Most HSCs commit to...
Lineage Commitment01:21

Lineage Commitment

Commitment is the  process whereby stem cells: